Literature DB >> 15820376

Antiphospholipid syndrome.

Angelo Ravelli1, Alberto Martini.   

Abstract

Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). APS has been recognized as the leading cause of vascular thrombosis in children. The diagnostic and therapeutic approach to APS in childhood may be different from that for adults and because of the rarity of aPL-related thrombosis in children, the natural history and optimal management of APS can be defined only through large, multicenter, controlled studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820376     DOI: 10.1016/j.pcl.2005.01.001

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  7 in total

1.  Essential thrombocytosis and antiphospholipid antibody syndrome causing chronic Budd-Chiari syndrome.

Authors:  Dinesh Yadav; Jagdish Chandra; Sunita Sharma; Varinder Singh
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

Review 2.  Current and future management of pediatric venous thromboembolism.

Authors:  Bryce A Kerlin
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

3.  When You are About to Diagnose Chronic Hemolytic Uremic Syndrome, Please Think More Deep.

Authors:  Doaa Mohammed Youssef; Doaa Mostafa Tawfeek
Journal:  Int J Nephrol       Date:  2010-10-25

Review 4.  Anti-phospholipid Antibodies and Smoking: An Overview.

Authors:  Steven R Binder; Christine M Litwin
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

5.  Thrombosis warning in children suffering from henoch-schonlein purpura.

Authors:  Luan Li; Jingwen Zhang; Yunying Zhang; Hong Ji
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

6.  Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.

Authors:  Surjit Singh; Mukesh Kumar Gupta; Jasmina Ahluwalia; Paramjeet Singh; Prahbhjot Malhi
Journal:  Rheumatol Int       Date:  2009-03-22       Impact factor: 2.631

7.  A case of catastrophic antiphospholipid syndrome presenting with acute respiratory distress syndrome as the initial manifestation.

Authors:  Kazushi Kinjo; Hiroya Terabe; Megumi Ogawa; Hideki Takeda; Doki Cho; Shinichi Hoshino; Takeshi Miyahira; Mariko Oshiro
Journal:  Rheumatol Int       Date:  2008-07-24       Impact factor: 3.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.